These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

834 related articles for article (PubMed ID: 32929324)

  • 21. Hyaluronan ameliorates LPS-induced acute lung injury in mice via Toll-like receptor (TLR) 4-dependent signaling pathways.
    Xu C; Chen G; Yang W; Xu Y; Xu Y; Huang X; Liu J; Feng Y; Xu Y; Liu B
    Int Immunopharmacol; 2015 Oct; 28(2):1050-8. PubMed ID: 26321117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Wogonin prevents lipopolysaccharide-induced acute lung injury and inflammation in mice via peroxisome proliferator-activated receptor gamma-mediated attenuation of the nuclear factor-kappaB pathway.
    Yao J; Pan D; Zhao Y; Zhao L; Sun J; Wang Y; You QD; Xi T; Guo QL; Lu N
    Immunology; 2014 Oct; 143(2):241-57. PubMed ID: 24766487
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protective effect of adenosine receptors against lipopolysaccharide-induced acute lung injury.
    Gonzales JN; Gorshkov B; Varn MN; Zemskova MA; Zemskov EA; Sridhar S; Lucas R; Verin AD
    Am J Physiol Lung Cell Mol Physiol; 2014 Mar; 306(6):L497-507. PubMed ID: 24414256
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Triptolide dose-dependently improves LPS-induced alveolar hypercoagulation and fibrinolysis inhibition through NF-κB inactivation in ARDS mice.
    Yang H; Qian H; Liu B; Wu Y; Cheng Y; Zheng X; Li X; Yang G; He T; Li S; Shen F
    Biomed Pharmacother; 2021 Jul; 139():111569. PubMed ID: 34243622
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Emodin improves alveolar hypercoagulation and inhibits pulmonary inflammation in LPS-provoked ARDS in mice via NF-κB inactivation.
    Liu B; Cheng Y; Wu Y; Zheng X; Li X; Yang G; He T; Li S; Shen F
    Int Immunopharmacol; 2020 Nov; 88():107020. PubMed ID: 33182048
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The therapeutic effects of Jaceosidin on lipopolysaccharide-induced acute lung injury in mice.
    Huang XL; Wei XC; Guo LQ; Zhao L; Chen XH; Cui YD; Yuan J; Chen DF; Zhang J
    J Pharmacol Sci; 2019 Jul; 140(3):228-235. PubMed ID: 31358372
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pretreatment of nafithromycin attenuates inflammatory response in murine lipopolysaccharide induced acute lung injury.
    Trivedi J; Shaikh J; Chavan N; Thorve D; Chaudhary B; Karade A; Gupta S; Patel A; Bhagwat S
    Cytokine; 2020 May; 129():155049. PubMed ID: 32126500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dexmedetomidine attenuates lipopolysaccharide induced acute lung injury in rats by inhibition of caveolin-1 downstream signaling.
    Liu J; Huang X; Hu S; He H; Meng Z
    Biomed Pharmacother; 2019 Oct; 118():109314. PubMed ID: 31545263
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ISM1 suppresses LPS-induced acute lung injury and post-injury lung fibrosis in mice.
    Nguyen N; Xu S; Lam TYW; Liao W; Wong WSF; Ge R
    Mol Med; 2022 Jun; 28(1):72. PubMed ID: 35752760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Daidzein attenuates lipopolysaccharide-induced acute lung injury via toll-like receptor 4/NF-kappaB pathway.
    Feng G; Sun B; Li TZ
    Int Immunopharmacol; 2015 Jun; 26(2):392-400. PubMed ID: 25887269
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Resolvin D1 attenuates inflammation in lipopolysaccharide-induced acute lung injury through a process involving the PPARγ/NF-κB pathway.
    Liao Z; Dong J; Wu W; Yang T; Wang T; Guo L; Chen L; Xu D; Wen F
    Respir Res; 2012 Dec; 13(1):110. PubMed ID: 23199346
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FGF1 alleviates LPS-induced acute lung injury via suppression of inflammation and oxidative stress.
    Dhlamini Q; Wang W; Feng G; Chen A; Chong L; Li X; Li Q; Wu J; Zhou D; Wang J; Zhang H; Zhang JS
    Mol Med; 2022 Jun; 28(1):73. PubMed ID: 35764933
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-inflammatory effects of novel curcumin analogs in experimental acute lung injury.
    Zhang Y; Liang D; Dong L; Ge X; Xu F; Chen W; Dai Y; Li H; Zou P; Yang S; Liang G
    Respir Res; 2015 Mar; 16(1):43. PubMed ID: 25889862
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Knockdown of TFPI-Anchored Endothelial Cells Exacerbates Lipopolysaccharide-Induced Acute Lung Injury Via NF-κB Signaling Pathway.
    Wang BQ; Shi M; Zhang JP; Wu X; Chang MJ; Chen ZH; Shen HH; Song YL; Zhou J; Bai CX
    Shock; 2019 Feb; 51(2):235-246. PubMed ID: 29438223
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glycyrrhizin inactivates toll-like receptor (TLR) signaling pathway to reduce lipopolysaccharide-induced acute lung injury by inhibiting TLR2.
    Kong D; Wang Z; Tian J; Liu T; Zhou H
    J Cell Physiol; 2019 Apr; 234(4):4597-4607. PubMed ID: 30203548
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gprc5a-deficiency confers susceptibility to endotoxin-induced acute lung injury via NF-κB pathway.
    Liao Y; Song H; Xu D; Jiao H; Yao F; Liu J; Wu Y; Zhong S; Yin H; Liu S; Wang X; Guo W; Sun B; Han B; Chin YE; Deng J
    Cell Cycle; 2015; 14(9):1403-12. PubMed ID: 25714996
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cavidine Ameliorates Lipopolysaccharide-Induced Acute Lung Injury via NF-κB Signaling Pathway in vivo and in vitro.
    Niu X; Liu F; Li W; Zhi W; Zhang H; Wang X; He Z
    Inflammation; 2017 Aug; 40(4):1111-1122. PubMed ID: 28365871
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isotetrandrine protects against lipopolysaccharide-induced acute lung injury by suppression of mitogen-activated protein kinase and nuclear factor-kappa B.
    Liang XM; Guo GF; Huang XH; Duan WL; Zeng ZL
    J Surg Res; 2014 Apr; 187(2):596-604. PubMed ID: 24331940
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ulinastatin inhibits the inflammation of LPS-induced acute lung injury in mice via regulation of AMPK/NF-κB pathway.
    Li W; Qiu X; Jiang H; Zhi Y; Fu J; Liu J
    Int Immunopharmacol; 2015 Dec; 29(2):560-567. PubMed ID: 26481965
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pirfenidone ameliorates lipopolysaccharide-induced pulmonary inflammation and fibrosis by blocking NLRP3 inflammasome activation.
    Li Y; Li H; Liu S; Pan P; Su X; Tan H; Wu D; Zhang L; Song C; Dai M; Li Q; Mao Z; Long Y; Hu Y; Hu C
    Mol Immunol; 2018 Jul; 99():134-144. PubMed ID: 29783158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.